SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
- Authors:
- more »
- Publication Date:
- Research Org.:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Org.:
- USDOE Office of Science (SC)
- OSTI Identifier:
- 1438922
- Resource Type:
- Journal Article
- Journal Name:
- Cancer Research
- Additional Journal Information:
- Journal Volume: 74; Journal Issue: 20; Journal ID: ISSN 0008-5472
- Publisher:
- American Association for Cancer Research
- Country of Publication:
- United States
- Language:
- ENGLISH
Citation Formats
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barriere, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., Hoffman-Luca, C. G., Lu, J., Shangary, S., Yu, S., Bernard, D., Aguilar, A., Dos-Santos, O., Besret, L., Guerif, S., Pannier, P., Gorge-Bernat, D., and Debussche, L. SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression. United States: N. p., 2014.
Web. doi:10.1158/0008-5472.CAN-14-0799.
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barriere, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., Hoffman-Luca, C. G., Lu, J., Shangary, S., Yu, S., Bernard, D., Aguilar, A., Dos-Santos, O., Besret, L., Guerif, S., Pannier, P., Gorge-Bernat, D., & Debussche, L. SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression. United States. https://doi.org/10.1158/0008-5472.CAN-14-0799
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barriere, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., Hoffman-Luca, C. G., Lu, J., Shangary, S., Yu, S., Bernard, D., Aguilar, A., Dos-Santos, O., Besret, L., Guerif, S., Pannier, P., Gorge-Bernat, D., and Debussche, L. 2014.
"SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression". United States. https://doi.org/10.1158/0008-5472.CAN-14-0799.
@article{osti_1438922,
title = {SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression},
author = {Wang, S. and Sun, W. and Zhao, Y. and McEachern, D. and Meaux, I. and Barriere, C. and Stuckey, J. A. and Meagher, J. L. and Bai, L. and Liu, L. and Hoffman-Luca, C. G. and Lu, J. and Shangary, S. and Yu, S. and Bernard, D. and Aguilar, A. and Dos-Santos, O. and Besret, L. and Guerif, S. and Pannier, P. and Gorge-Bernat, D. and Debussche, L.},
abstractNote = {},
doi = {10.1158/0008-5472.CAN-14-0799},
url = {https://www.osti.gov/biblio/1438922},
journal = {Cancer Research},
issn = {0008-5472},
number = 20,
volume = 74,
place = {United States},
year = {Thu Aug 21 00:00:00 EDT 2014},
month = {Thu Aug 21 00:00:00 EDT 2014}
}
Other availability
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
p53 and Human Cancer: The First Ten Thousand Mutations
book, January 1999
- Hainaut, Pierre; Hollstein, Monica
- Advances in Cancer Research
The p53-mdm-2 autoregulatory feedback loop.
journal, July 1993
- Wu, X.; Bayle, J. H.; Olson, D.
- Genes & Development, Vol. 7, Issue 7a
Functions of the MDM2 oncoprotein
journal, January 1999
- Freedman, D. A.; Wu, L.; Levine, A. J.
- Cellular and Molecular Life Sciences CMLS, Vol. 55, Issue 1
MDM2 — master regulator of the p53 tumor suppressor protein
journal, January 2000
- Momand, Jamil; Wu, Hsiao-Huei; Dasgupta, Gargi
- Gene, Vol. 242, Issue 1-2
MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
journal, February 2005
- Bond, Gareth; Hu, Wenwei; Levine, Arnold
- Current Cancer Drug Targets, Vol. 5, Issue 1
The MDM2 gene amplification database
journal, August 1998
- Momand, J.
- Nucleic Acids Research, Vol. 26, Issue 15
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
journal, February 2004
- Vassilev, L. T.
- Science, Vol. 303, Issue 5659
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
journal, March 2008
- Shangary, S.; Qin, D.; McEachern, D.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 10
p53 Activation by Small Molecules: Application in Oncology
journal, July 2005
- Vassilev, Lyubomir T.
- Journal of Medicinal Chemistry, Vol. 48, Issue 14
MDM2 inhibitors for cancer therapy
journal, January 2007
- Vassilev, Lyubomir T.
- Trends in Molecular Medicine, Vol. 13, Issue 1
Targeting the MDM2-p53 Interaction for Cancer Therapy
journal, September 2008
- Shangary, Sanjeev; Wang, Shaomeng
- Clinical Cancer Research, Vol. 14, Issue 17
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
book, January 2012
- Wang, Shaomeng; Zhao, Yujun; Bernard, Denzil
- Protein-Protein Interactions
Inhibitors of the p53/hdm2 protein–protein interaction—path to the clinic
journal, May 2013
- Carry, Jean-Christophe; Garcia-Echeverria, Carlos
- Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 9
A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
journal, June 2013
- Zhao, Yujun; Yu, Shanghai; Sun, Wei
- Journal of Medicinal Chemistry, Vol. 56, Issue 13
Design of Bcl-2 and Bcl-xL Inhibitors with Subnanomolar Binding Affinities Based upon a New Scaffold
journal, May 2012
- Zhou, Haibin; Chen, Jianfang; Meagher, Jennifer L.
- Journal of Medicinal Chemistry, Vol. 55, Issue 10
Analysis of the Interaction of BCL9 with β-Catenin and Development of Fluorescence Polarization and Surface Plasmon Resonance Binding Assays for this Interaction
journal, September 2009
- Kawamoto, Steven A.; Thompson, Andrea D.; Coleska, Adriana
- Biochemistry, Vol. 48, Issue 40
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
journal, September 2009
- Concepcion, Joy; Witte, Krista; Wartchow, Charles
- Combinatorial Chemistry & High Throughput Screening, Vol. 12, Issue 8
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
journal, January 2002
- Lois, C.
- Science, Vol. 295, Issue 5556
Phaser crystallographic software
journal, July 2007
- McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
- Journal of Applied Crystallography, Vol. 40, Issue 4
Coot model-building tools for molecular graphics
journal, November 2004
- Emsley, Paul; Cowtan, Kevin
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
journal, June 2007
- Teodoro, Jose G.; Evans, Sara K.; Green, Michael R.
- Journal of Molecular Medicine, Vol. 85, Issue 11
A Novel BH3 Mimetic Reveals a Mitogen-Activated Protein Kinase–Dependent Mechanism of Melanoma Cell Death Controlled by p53 and Reactive Oxygen Species
journal, December 2006
- Verhaegen, Monique; Bauer, Joshua A.; Martín de la Vega, Cristina
- Cancer Research, Vol. 66, Issue 23
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
journal, May 2005
- Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.
- Nature, Vol. 435, Issue 7042
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
journal, December 2012
- Friberg, Anders; Vigil, Dominico; Zhao, Bin
- Journal of Medicinal Chemistry, Vol. 56, Issue 1
Crystal Structure of a β-Catenin/BCL9/Tcf4 Complex
journal, October 2006
- Sampietro, James; Dahlberg, Caroline L.; Cho, Uhn Soo
- Molecular Cell, Vol. 24, Issue 2
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
journal, November 1996
- Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent
- Science, Vol. 274, Issue 5289
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
journal, January 2006
- Tovar, C.; Rosinski, J.; Filipovic, Z.
- Proceedings of the National Academy of Sciences, Vol. 103, Issue 6
How the Bcl-2 family of proteins interact to regulate apoptosis
journal, February 2006
- van Delft, Mark F.; Huang, David CS
- Cell Research, Vol. 16, Issue 2
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
journal, January 1995
- Toshiyuki, Miyashita; Reed, John C.
- Cell, Vol. 80, Issue 2
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
journal, May 2000
- Oda, E.
- Science, Vol. 288, Issue 5468
Differential contribution of Puma and Noxa in dual regulation of p53-mediated apoptotic pathways
journal, October 2006
- Shibue, Tsukasa; Suzuki, Saori; Okamoto, Hideaki
- The EMBO Journal, Vol. 25, Issue 20
Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction
journal, May 2012
- Rew, Yosup; Sun, Daqing; Gonzalez-Lopez De Turiso, Felix
- Journal of Medicinal Chemistry, Vol. 55, Issue 11
MDM2 Small-Molecule Antagonist RG7112 Activates p53 Signaling and Regresses Human Tumors in Preclinical Cancer Models
journal, February 2013
- Tovar, C.; Graves, B.; Packman, K.
- Cancer Research, Vol. 73, Issue 8
Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors
journal, May 2013
- Zhao, Yujun; Liu, Liu; Sun, Wei
- Journal of the American Chemical Society, Vol. 135, Issue 19
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
journal, December 2006
- Martins, Carla P.; Brown-Swigart, Lamorna; Evan, Gerard I.
- Cell, Vol. 127, Issue 7
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
journal, January 2007
- Xue, Wen; Zender, Lars; Miething, Cornelius
- Nature, Vol. 445, Issue 7128
Restoration of p53 function leads to tumour regression in vivo
journal, January 2007
- Ventura, Andrea; Kirsch, David G.; McLaughlin, Margaret E.
- Nature, Vol. 445, Issue 7128
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms
journal, August 2008
- Weaver, Joshua; Downs-Kelly, Erinn; Goldblum, John R.
- Modern Pathology, Vol. 21, Issue 8
Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma
journal, January 2009
- Weaver, Joshua; Goldblum, John R.; Turner, Sondra
- Modern Pathology, Vol. 22, Issue 1
Works referencing / citing this record:
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
journal, October 2018
- Skalniak, Lukasz; Kocik, Justyna; Polak, Justyna
- Cancers, Vol. 10, Issue 11
Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles
journal, December 2014
- Aguilar, Angelo; Sun, Wei; Liu, Liu
- Journal of Medicinal Chemistry, Vol. 57, Issue 24
Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53—MDM2 protein-protein interaction
journal, March 2018
- Beloglazkina, A. А.; Skvortsov, D. А.; Tafeenko, V. A.
- Russian Chemical Bulletin, Vol. 67, Issue 3
Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment
journal, October 2015
- Kadakia, Kunal C.; Tomlins, Scott A.; Sanghvi, Saagar K.
- Journal of Hematology & Oncology, Vol. 8, Issue 1
How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures
journal, December 2015
- Estrada-Ortiz, Natalia; Neochoritis, Constantinos G.; Dömling, Alexander
- ChemMedChem, Vol. 11, Issue 8
Early and multiple origins of metastatic lineages within primary tumors
journal, February 2016
- Zhao, Zi-Ming; Zhao, Bixiao; Bai, Yalai
- Proceedings of the National Academy of Sciences, Vol. 113, Issue 8
The catalytic asymmetric synthesis of CF 3 -containing spiro-oxindole–pyrrolidine–pyrazolone compounds through squaramide-catalyzed 1,3-dipolar cycloaddition
journal, January 2019
- Wang, Cui; Wen, Dongwa; Chen, Hui
- Organic & Biomolecular Chemistry, Vol. 17, Issue 22
JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells
journal, May 2017
- Tan, Guobin; Qiu, Mingning; Chen, Lieqian
- BMC Cancer, Vol. 17, Issue 1
Identification of a new class of natural product MDM2 inhibitor:In vitroandin vivoanti-breast cancer activities and target validation
journal, December 2014
- Qin, Jiang-Jiang; Wang, Wei; Voruganti, Sukesh
- Oncotarget, Vol. 6, Issue 5
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner
journal, April 2016
- Feng, Felix Y.; Zhang, Yu; Kothari, Vishal
- Neoplasia, Vol. 18, Issue 4
The chemistry and pharmacology of privileged pyrroloquinazolines
journal, January 2015
- Chao, Bo; Li, Bingbing X.; Xiao, Xiangshu
- MedChemComm, Vol. 6, Issue 4
Discovery of 4-((3′R,4′S,5′R)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development
journal, March 2017
- Aguilar, Angelo; Lu, Jianfeng; Liu, Liu
- Journal of Medicinal Chemistry, Vol. 60, Issue 7
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
journal, July 2017
- Tisato, Veronica; Voltan, Rebecca; Gonelli, Arianna
- Journal of Hematology & Oncology, Vol. 10, Issue 1
Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma
journal, October 2016
- Lu, Jiaxiong; Guan, Shan; Zhao, Yanling
- Oncotarget, Vol. 7, Issue 50
Therapeutic targeting of tumor suppressor genes: Therapeutic Targeting of Tumors
journal, December 2014
- Morris, Luc G. T.; Chan, Timothy A.
- Cancer, Vol. 121, Issue 9
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity
journal, November 2019
- Ristau, Johannes; van Hoef, Vincent; Peuget, Sylvain
- Cell Death & Disease, Vol. 10, Issue 11
Organocatalytic cascade reaction for the asymmetric synthesis of novel chroman-fused spirooxindoles that potently inhibit cancer cell proliferation
journal, January 2015
- Zhou, Rui; Wu, Qinjie; Guo, Mingrui
- Chemical Communications, Vol. 51, Issue 66
Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
journal, January 2018
- Zhang, Meiqiongzi; Heldin, Angelos; Palomar-Siles, Mireia
- Frontiers in Oncology, Vol. 7
Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations
journal, April 2019
- Leung, Garret M. K.; Zhang, Chunxiao; Ng, Nelson K. L.
- American Journal of Hematology, Vol. 94, Issue 6
Comprehensive serial molecular profiling of an “N of 1” exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment
journal, October 2015
- Kadakia, Kunal C.; Tomlins, Scott A.; Sanghvi, Saagar K.
- Journal of Hematology & Oncology, Vol. 8, Issue 1
The Role of MDM2 in Promoting Genome Stability versus Instability
journal, October 2017
- Saadatzadeh, M.; Elmi, Adily; Pandya, Pankita
- International Journal of Molecular Sciences, Vol. 18, Issue 10
The utilization of spirocyclic scaffolds in novel drug discovery
journal, June 2016
- Zheng, Ya-Jun; Tice, Colin M.
- Expert Opinion on Drug Discovery, Vol. 11, Issue 9
Chemical Variations on the p53 Reactivation Theme
journal, May 2016
- Ribeiro, Carlos; Rodrigues, Cecília; Moreira, Rui
- Pharmaceuticals, Vol. 9, Issue 2
Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors
journal, March 2017
- Ohnami, Shumpei; Ohshima, Keiichi; Nagashima, Takeshi
- Molecular and Cellular Biochemistry, Vol. 431, Issue 1-2
RSK3: A regulator of pathological cardiac remodeling: Regulation and Function of RSK3 in Cardiac Remodeling
journal, May 2015
- Martinez, Eliana C.; Passariello, Catherine L.; Li, Jinliang
- IUBMB Life, Vol. 67, Issue 5
2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014)
journal, December 2015
- Leoni, Alberto; Locatelli, Alessandra; Morigi, Rita
- Expert Opinion on Therapeutic Patents, Vol. 26, Issue 2
A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation
journal, January 2019
- Amaral, Joana D.; Silva, Dário; Rodrigues, Cecília M. P.
- Frontiers in Chemistry, Vol. 7
Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53–MDM2 Interaction Useful in Targeted Cancer Therapy
journal, December 2016
- Gupta, Alpana K.; Bharadwaj, Mausumi; Kumar, Anoop
- Topics in Current Chemistry, Vol. 375, Issue 1
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
journal, July 2018
- Her, Nam-Gu; Oh, Jeong-Woo; Oh, Yun Jeong
- Cell Death & Disease, Vol. 9, Issue 8
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
journal, July 2017
- Tisato, Veronica; Voltan, Rebecca; Gonelli, Arianna
- Journal of Hematology & Oncology, Vol. 10, Issue 1
Efficient Synthesis of Fully Substituted Pyrrolidine-Fused 3-Spirooxindoles via 1,3-Dipolar Cycloaddition of Aziridine and 3-Ylideneoxindole
journal, August 2016
- Ren, Wen; Zhao, Qian; Zheng, Chuan
- Molecules, Vol. 21, Issue 9
The role of p53 in cancer drug resistance and targeted chemotherapy
journal, November 2016
- Hientz, Karin; Mohr, André; Bhakta-Guha, Dipita
- Oncotarget, Vol. 8, Issue 5
A fluorinated indole‐based MDM 2 antagonist selectively inhibits the growth of p53 wt osteosarcoma cells
journal, February 2019
- Skalniak, Lukasz; Twarda‐Clapa, Aleksandra; Neochoritis, Constantinos G.
- The FEBS Journal, Vol. 286, Issue 7
Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
journal, April 2017
- Chen, Haibo; Luo, Dingyuan; Zhang, Lin
- Oncotarget, Vol. 8, Issue 26
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
journal, December 2017
- Gavory, Gerald; O'Dowd, Colin R.; Helm, Matthew D.
- Nature Chemical Biology, Vol. 14, Issue 2
Targeting MDM2 for novel molecular therapy: Beyond oncology
journal, October 2019
- Wang, Wei; Qin, Jiang‐Jiang; Rajaei, Mehrdad
- Medicinal Research Reviews, Vol. 40, Issue 3
A regio- and stereocontrolled approach to the synthesis of 4-CF 3 -substituted spiro[chromeno[3,4- c ]pyrrolidine-oxindoles] via reversible [3+2] cycloaddition of azomethine ylides generated from isatins and sarcosine to 3-nitro-2-(trifluoromethyl)-2 H -chromenes
journal, January 2019
- Kutyashev, Igor B.; Ulitko, Maria V.; Barkov, Alexey Yu.
- New Journal of Chemistry, Vol. 43, Issue 47
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein–protein interactions identifies a novel putative Mdm2-binding site in p53
journal, November 2017
- Wong, Jin Huei; Alfatah, Mohammad; Sin, Mei Fang
- BMC Biology, Vol. 15, Issue 1
Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy: ANTICANCER COMPOUNDS TARGETING CELL DEATH
journal, June 2016
- Ke, Bowen; Tian, Mao; Li, Jingjing
- Medicinal Research Reviews, Vol. 36, Issue 6
Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists
journal, July 2019
- Kocik, Justyna; Machula, Monika; Wisniewska, Aneta
- Cancers, Vol. 11, Issue 7
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction: STRATEGIES TO DISRUPT THE p53-MDM2/MDMX INTERACTION
journal, June 2016
- Lemos, Agostinho; Leão, Mariana; Soares, Joana
- Medicinal Research Reviews, Vol. 36, Issue 5
Synthesis of benzosuberone-tethered spirooxindoles: 1-3-dipolar cycloaddition of azomethine ylides and arylidene benzosuberones
journal, December 2018
- Kumar, Sundaravel Vivek; Rani, Gandhi Uma; Divyalakshmi, Manohar
- Molecular Diversity, Vol. 23, Issue 3
Efficient synthesis of tetrahydronaphthalene- or isochroman-fused spirooxindoles using tandem reactions
journal, January 2015
- Wang, Biao; Leng, Hai-Jun; Yang, Xue-Yuan
- RSC Advances, Vol. 5, Issue 107
Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
journal, February 2015
- Vlachostergios, Panagiotis J.; Papandreou, Christos N.
- Frontiers in Oncology, Vol. 5
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
journal, August 2017
- Hata, A. N.; Rowley, S.; Archibald, H. L.
- Oncogene, Vol. 36, Issue 47
Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
journal, August 2018
- Macalino, Stephani Joy Y.; Basith, Shaherin; Clavio, Nina Abigail B.
- Molecules, Vol. 23, Issue 8
Efficient Synthesis of Fully Substituted Pyrrolidine-Fused 3-Spirooxindoles via 1,3-Dipolar Cycloaddition of Aziridine and 3-Ylideneoxindole
journal, August 2016
- Ren, Wen; Zhao, Qian; Zheng, Chuan
- Molecules, Vol. 21, Issue 9
Chiral bifunctional bisphosphine enabled enantioselective tandem Michael addition of tryptamine-derived oxindoles to ynones
journal, January 2019
- Cong, Tiantian; Wang, Huamin; Li, Xiuzheng
- Chemical Communications, Vol. 55, Issue 62
A therapeutic patent overview of MDM2/X-targeted therapies (2014–2018)
journal, March 2019
- Skalniak, Lukasz; Surmiak, Ewa; Holak, Tad A.
- Expert Opinion on Therapeutic Patents, Vol. 29, Issue 3
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
journal, October 2018
- Skalniak, Lukasz; Kocik, Justyna; Polak, Justyna
- Cancers, Vol. 10, Issue 11
Design, synthesis and evaluations of spiro‐fused benzoxaborin derivatives as novel boron‐containing compounds
journal, March 2019
- Natsutani, Itaru; Iwata, Riyo; Yamai, Yu‐suke
- Chemical Biology & Drug Design, Vol. 93, Issue 5
Targeting Transcription Factors for Cancer Treatment
journal, June 2018
- Lambert, Mélanie; Jambon, Samy; Depauw, Sabine
- Molecules, Vol. 23, Issue 6
Organocatalytic asymmetric Michael addition between 3-subsituted oxindoles and enals catalyzed by camphor sulfonyl hydrazine
journal, January 2019
- Cheng, Wen-Fu; Chen, Ling-Yan; Xu, Fang-Fang
- Organic & Biomolecular Chemistry, Vol. 17, Issue 4
Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments
journal, May 2019
- Suarez-Kelly, Lorena P.; Baldi, Giacomo G.; Gronchi, Alessandro
- Expert Opinion on Pharmacotherapy, Vol. 20, Issue 12
Targeting transcription factors in acute myeloid leukemia
journal, June 2018
- Takei, Hisashi; Kobayashi, Susumu S.
- International Journal of Hematology, Vol. 109, Issue 1
The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53
journal, October 2019
- Sandoval, Jonathan E.; Reich, Norbert O.
- Journal of Biological Chemistry, Vol. 294, Issue 48
Modulation of Protein–Protein Interactions for the Development of Novel Therapeutics
journal, April 2016
- Petta, Ioanna; Lievens, Sam; Libert, Claude
- Molecular Therapy, Vol. 24, Issue 4
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein–protein interactions identifies a novel putative Mdm2-binding site in p53
journal, November 2017
- Wong, Jin Huei; Alfatah, Mohammad; Sin, Mei Fang
- BMC Biology, Vol. 15, Issue 1
Targeting the MDM2–p53 Protein–Protein Interaction for New Cancer Therapy: Progress and Challenges
journal, March 2017
- Wang, Shaomeng; Zhao, Yujun; Aguilar, Angelo
- Cold Spring Harbor Perspectives in Medicine, Vol. 7, Issue 5
JS-K, a nitric oxide pro-drug, regulates growth and apoptosis through the ubiquitin-proteasome pathway in prostate cancer cells
journal, May 2017
- Tan, Guobin; Qiu, Mingning; Chen, Lieqian
- BMC Cancer, Vol. 17, Issue 1
Cellular Senescence: Aging, Cancer, and Injury
journal, April 2019
- Calcinotto, Arianna; Kohli, Jaskaren; Zagato, Elena
- Physiological Reviews, Vol. 99, Issue 2
P53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis
journal, March 2016
- Mahfoudhi, Emna; Lordier, Larissa; Marty, Caroline
- Oncotarget, Vol. 7, Issue 22
Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
journal, November 2019
- Frosi, Y.; Inoue, K.; Ramlan, Siti Radhiah
- Scientific Reports, Vol. 9, Issue 1